ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Intravenous Solutions (Colloids) Market Research Report 2026
Published Date: 2026-03-05
|
Report Code: QYRE-Auto-32N82
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Intravenous Solutions Colloids Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
BUY CHAPTERS

Global Intravenous Solutions (Colloids) Market Research Report 2026

Code: QYRE-Auto-32N82
Report
2026-03-05
Pages:111
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
ICU Medical Inc
B Braun Melsungen AG
Fresenius Kabi AG
Baxter
Amanta Healthcare
Terumo Medical Corporation
Grifols S A

Intravenous Solutions (Colloids) Market

The global Intravenous Solutions (Colloids) market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Intravenous Solutions (Colloids) competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
There are two types of IVFs, crystalloid and colloid solutions. Crystalloid solutions are used to treat most patients with shock from dengue, while colloids are reserved for patients with profound or refractory shock.
Global Intravenous Solutions (Colloids) key players include ICU Medical Inc., B. Braun Melsungen AG, Fresenius Kabi AG, etc.
This report delivers a comprehensive overview of the global Intravenous Solutions (Colloids) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Intravenous Solutions (Colloids). The Intravenous Solutions (Colloids) market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Intravenous Solutions (Colloids) market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Intravenous Solutions (Colloids) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Intravenous Solutions (Colloids) Market Report

Report Metric Details
Report Name Intravenous Solutions (Colloids) Market
Segment by Type
  • Peripheral Parenteral Nutrition
  • Total Parenteral Nutrition
by Application
  • Hospital and Clinics
  • Ambulatory
  • Home Care
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company ICU Medical Inc., B. Braun Melsungen AG, Fresenius Kabi AG, Baxter, Amanta Healthcare, Terumo Medical Corporation, Grifols S.A.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Intravenous Solutions (Colloids) manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Intravenous Solutions (Colloids) sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Intravenous Solutions (Colloids) Market report?

Ans: The main players in the Intravenous Solutions (Colloids) Market are ICU Medical Inc., B. Braun Melsungen AG, Fresenius Kabi AG, Baxter, Amanta Healthcare, Terumo Medical Corporation, Grifols S.A.

What are the Application segmentation covered in the Intravenous Solutions (Colloids) Market report?

Ans: The Applications covered in the Intravenous Solutions (Colloids) Market report are Hospital and Clinics, Ambulatory, Home Care

What are the Type segmentation covered in the Intravenous Solutions (Colloids) Market report?

Ans: The Types covered in the Intravenous Solutions (Colloids) Market report are Peripheral Parenteral Nutrition, Total Parenteral Nutrition

1 Intravenous Solutions (Colloids) Market Overview
1.1 Product Definition
1.2 Intravenous Solutions (Colloids) by Type
1.2.1 Global Intravenous Solutions (Colloids) Market Value by Type: 2025 vs 2032
1.2.2 Peripheral Parenteral Nutrition
1.2.3 Total Parenteral Nutrition
1.3 Intravenous Solutions (Colloids) by Application
1.3.1 Global Intravenous Solutions (Colloids) Market Value by Application: 2025 vs 2032
1.3.2 Hospital and Clinics
1.3.3 Ambulatory
1.3.4 Home Care
1.4 Global Intravenous Solutions (Colloids) Market Size Estimates and Forecasts
1.4.1 Global Intravenous Solutions (Colloids) Revenue 2021–2032
1.4.2 Global Intravenous Solutions (Colloids) Sales 2021–2032
1.4.3 Global Intravenous Solutions (Colloids) Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Intravenous Solutions (Colloids) Market Competition by Manufacturers
2.1 Global Intravenous Solutions (Colloids) Sales Market Share by Manufacturers (2021–2026)
2.2 Global Intravenous Solutions (Colloids) Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Intravenous Solutions (Colloids) Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Intravenous Solutions (Colloids), Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Intravenous Solutions (Colloids), Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Intravenous Solutions (Colloids), Product Types and Applications
2.7 Global Key Manufacturers of Intravenous Solutions (Colloids), Date of Entry into the Industry
2.8 Global Intravenous Solutions (Colloids) Market Competitive Situation and Trends
2.8.1 Global Intravenous Solutions (Colloids) Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Intravenous Solutions (Colloids) Players Market Share by Revenue
2.8.3 Global Intravenous Solutions (Colloids) Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Intravenous Solutions (Colloids) Market Scenario by Region
3.1 Global Intravenous Solutions (Colloids) Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Intravenous Solutions (Colloids) Sales by Region: 2021–2032
3.2.1 Global Intravenous Solutions (Colloids) Sales by Region: 2021–2026
3.2.2 Global Intravenous Solutions (Colloids) Sales by Region: 2027–2032
3.3 Global Intravenous Solutions (Colloids) Revenue by Region: 2021–2032
3.3.1 Global Intravenous Solutions (Colloids) Revenue by Region: 2021–2026
3.3.2 Global Intravenous Solutions (Colloids) Revenue by Region: 2027–2032
3.4 North America Intravenous Solutions (Colloids) Market Facts & Figures by Country
3.4.1 North America Intravenous Solutions (Colloids) Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Intravenous Solutions (Colloids) Sales by Country (2021–2032)
3.4.3 North America Intravenous Solutions (Colloids) Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Intravenous Solutions (Colloids) Market Facts & Figures by Country
3.5.1 Europe Intravenous Solutions (Colloids) Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Intravenous Solutions (Colloids) Sales by Country (2021–2032)
3.5.3 Europe Intravenous Solutions (Colloids) Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intravenous Solutions (Colloids) Market Facts & Figures by Region
3.6.1 Asia Pacific Intravenous Solutions (Colloids) Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Intravenous Solutions (Colloids) Sales by Region (2021–2032)
3.6.3 Asia Pacific Intravenous Solutions (Colloids) Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Intravenous Solutions (Colloids) Market Facts & Figures by Country
3.7.1 Latin America Intravenous Solutions (Colloids) Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Intravenous Solutions (Colloids) Sales by Country (2021–2032)
3.7.3 Latin America Intravenous Solutions (Colloids) Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Intravenous Solutions (Colloids) Market Facts & Figures by Country
3.8.1 Middle East and Africa Intravenous Solutions (Colloids) Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Intravenous Solutions (Colloids) Sales by Country (2021–2032)
3.8.3 Middle East and Africa Intravenous Solutions (Colloids) Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Intravenous Solutions (Colloids) Sales by Type (2021–2032)
4.1.1 Global Intravenous Solutions (Colloids) Sales by Type (2021–2026)
4.1.2 Global Intravenous Solutions (Colloids) Sales by Type (2027–2032)
4.1.3 Global Intravenous Solutions (Colloids) Sales Market Share by Type (2021–2032)
4.2 Global Intravenous Solutions (Colloids) Revenue by Type (2021–2032)
4.2.1 Global Intravenous Solutions (Colloids) Revenue by Type (2021–2026)
4.2.2 Global Intravenous Solutions (Colloids) Revenue by Type (2027–2032)
4.2.3 Global Intravenous Solutions (Colloids) Revenue Market Share by Type (2021–2032)
4.3 Global Intravenous Solutions (Colloids) Price by Type (2021–2032)
5 Segment by Application
5.1 Global Intravenous Solutions (Colloids) Sales by Application (2021–2032)
5.1.1 Global Intravenous Solutions (Colloids) Sales by Application (2021–2026)
5.1.2 Global Intravenous Solutions (Colloids) Sales by Application (2027–2032)
5.1.3 Global Intravenous Solutions (Colloids) Sales Market Share by Application (2021–2032)
5.2 Global Intravenous Solutions (Colloids) Revenue by Application (2021–2032)
5.2.1 Global Intravenous Solutions (Colloids) Revenue by Application (2021–2026)
5.2.2 Global Intravenous Solutions (Colloids) Revenue by Application (2027–2032)
5.2.3 Global Intravenous Solutions (Colloids) Revenue Market Share by Application (2021–2032)
5.3 Global Intravenous Solutions (Colloids) Price by Application (2021–2032)
6 Key Companies Profiled
6.1 ICU Medical Inc.
6.1.1 ICU Medical Inc. Company Information
6.1.2 ICU Medical Inc. Description and Business Overview
6.1.3 ICU Medical Inc. Intravenous Solutions (Colloids) Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 ICU Medical Inc. Intravenous Solutions (Colloids) Product Portfolio
6.1.5 ICU Medical Inc. Recent Developments/Updates
6.2 B. Braun Melsungen AG
6.2.1 B. Braun Melsungen AG Company Information
6.2.2 B. Braun Melsungen AG Description and Business Overview
6.2.3 B. Braun Melsungen AG Intravenous Solutions (Colloids) Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 B. Braun Melsungen AG Intravenous Solutions (Colloids) Product Portfolio
6.2.5 B. Braun Melsungen AG Recent Developments/Updates
6.3 Fresenius Kabi AG
6.3.1 Fresenius Kabi AG Company Information
6.3.2 Fresenius Kabi AG Description and Business Overview
6.3.3 Fresenius Kabi AG Intravenous Solutions (Colloids) Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Fresenius Kabi AG Intravenous Solutions (Colloids) Product Portfolio
6.3.5 Fresenius Kabi AG Recent Developments/Updates
6.4 Baxter
6.4.1 Baxter Company Information
6.4.2 Baxter Description and Business Overview
6.4.3 Baxter Intravenous Solutions (Colloids) Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Baxter Intravenous Solutions (Colloids) Product Portfolio
6.4.5 Baxter Recent Developments/Updates
6.5 Amanta Healthcare
6.5.1 Amanta Healthcare Company Information
6.5.2 Amanta Healthcare Description and Business Overview
6.5.3 Amanta Healthcare Intravenous Solutions (Colloids) Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Amanta Healthcare Intravenous Solutions (Colloids) Product Portfolio
6.5.5 Amanta Healthcare Recent Developments/Updates
6.6 Terumo Medical Corporation
6.6.1 Terumo Medical Corporation Company Information
6.6.2 Terumo Medical Corporation Description and Business Overview
6.6.3 Terumo Medical Corporation Intravenous Solutions (Colloids) Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Terumo Medical Corporation Intravenous Solutions (Colloids) Product Portfolio
6.6.5 Terumo Medical Corporation Recent Developments/Updates
6.7 Grifols S.A.
6.7.1 Grifols S.A. Company Information
6.7.2 Grifols S.A. Description and Business Overview
6.7.3 Grifols S.A. Intravenous Solutions (Colloids) Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Grifols S.A. Intravenous Solutions (Colloids) Product Portfolio
6.7.5 Grifols S.A. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intravenous Solutions (Colloids) Industry Chain Analysis
7.2 Intravenous Solutions (Colloids) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intravenous Solutions (Colloids) Production Mode & Process Analysis
7.4 Intravenous Solutions (Colloids) Sales and Marketing
7.4.1 Intravenous Solutions (Colloids) Sales Channels
7.4.2 Intravenous Solutions (Colloids) Distributors
7.5 Intravenous Solutions (Colloids) Customer Analysis
8 Intravenous Solutions (Colloids) Market Dynamics
8.1 Intravenous Solutions (Colloids) Industry Trends
8.2 Intravenous Solutions (Colloids) Market Drivers
8.3 Intravenous Solutions (Colloids) Market Challenges
8.4 Intravenous Solutions (Colloids) Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
ICU Medical Inc
B Braun Melsungen AG
Fresenius Kabi AG
Baxter
Amanta Healthcare
Terumo Medical Corporation
Grifols S A
List of Tables
 Table 1. Global Intravenous Solutions (Colloids) Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Intravenous Solutions (Colloids) Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Intravenous Solutions (Colloids) Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Intravenous Solutions (Colloids) Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Intravenous Solutions (Colloids) Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Intravenous Solutions (Colloids) Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Intravenous Solutions (Colloids) Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Intravenous Solutions (Colloids) Average Price (USD/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Intravenous Solutions (Colloids), Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Intravenous Solutions (Colloids), Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Intravenous Solutions (Colloids), Product Types and Applications
 Table 12. Global Key Manufacturers of Intravenous Solutions (Colloids), Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Intravenous Solutions (Colloids) Companies by Tier (Tier 1, Tier 2, Tier 3), based on Intravenous Solutions (Colloids) Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Intravenous Solutions (Colloids) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Intravenous Solutions (Colloids) Sales by Region (K Units), 2021–2026
 Table 18. Global Intravenous Solutions (Colloids) Sales Market Share by Region (2021–2026)
 Table 19. Global Intravenous Solutions (Colloids) Sales by Region (K Units), 2027–2032
 Table 20. Global Intravenous Solutions (Colloids) Sales Market Share by Region (2027–2032)
 Table 21. Global Intravenous Solutions (Colloids) Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Intravenous Solutions (Colloids) Revenue Market Share by Region (2021–2026)
 Table 23. Global Intravenous Solutions (Colloids) Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Intravenous Solutions (Colloids) Revenue Market Share by Region (2027–2032)
 Table 25. North America Intravenous Solutions (Colloids) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Intravenous Solutions (Colloids) Sales by Country (K Units), 2021–2026
 Table 27. North America Intravenous Solutions (Colloids) Sales by Country (K Units), 2027–2032
 Table 28. North America Intravenous Solutions (Colloids) Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Intravenous Solutions (Colloids) Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Intravenous Solutions (Colloids) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Intravenous Solutions (Colloids) Sales by Country (K Units), 2021–2026
 Table 32. Europe Intravenous Solutions (Colloids) Sales by Country (K Units), 2027–2032
 Table 33. Europe Intravenous Solutions (Colloids) Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Intravenous Solutions (Colloids) Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Intravenous Solutions (Colloids) Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Intravenous Solutions (Colloids) Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Intravenous Solutions (Colloids) Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Intravenous Solutions (Colloids) Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Intravenous Solutions (Colloids) Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Intravenous Solutions (Colloids) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Intravenous Solutions (Colloids) Sales by Country (K Units), 2021–2026
 Table 42. Latin America Intravenous Solutions (Colloids) Sales by Country (K Units), 2027–2032
 Table 43. Latin America Intravenous Solutions (Colloids) Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Intravenous Solutions (Colloids) Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Intravenous Solutions (Colloids) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Intravenous Solutions (Colloids) Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Intravenous Solutions (Colloids) Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Intravenous Solutions (Colloids) Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Intravenous Solutions (Colloids) Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Intravenous Solutions (Colloids) Sales (K Units) by Type (2021–2026)
 Table 51. Global Intravenous Solutions (Colloids) Sales (K Units) by Type (2027–2032)
 Table 52. Global Intravenous Solutions (Colloids) Sales Market Share by Type (2021–2026)
 Table 53. Global Intravenous Solutions (Colloids) Sales Market Share by Type (2027–2032)
 Table 54. Global Intravenous Solutions (Colloids) Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Intravenous Solutions (Colloids) Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Intravenous Solutions (Colloids) Revenue Market Share by Type (2021–2026)
 Table 57. Global Intravenous Solutions (Colloids) Revenue Market Share by Type (2027–2032)
 Table 58. Global Intravenous Solutions (Colloids) Price (USD/Unit) by Type (2021–2026)
 Table 59. Global Intravenous Solutions (Colloids) Price (USD/Unit) by Type (2027–2032)
 Table 60. Global Intravenous Solutions (Colloids) Sales (K Units) by Application (2021–2026)
 Table 61. Global Intravenous Solutions (Colloids) Sales (K Units) by Application (2027–2032)
 Table 62. Global Intravenous Solutions (Colloids) Sales Market Share by Application (2021–2026)
 Table 63. Global Intravenous Solutions (Colloids) Sales Market Share by Application (2027–2032)
 Table 64. Global Intravenous Solutions (Colloids) Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Intravenous Solutions (Colloids) Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Intravenous Solutions (Colloids) Revenue Market Share by Application (2021–2026)
 Table 67. Global Intravenous Solutions (Colloids) Revenue Market Share by Application (2027–2032)
 Table 68. Global Intravenous Solutions (Colloids) Price (USD/Unit) by Application (2021–2026)
 Table 69. Global Intravenous Solutions (Colloids) Price (USD/Unit) by Application (2027–2032)
 Table 70. ICU Medical Inc. Company Information
 Table 71. ICU Medical Inc. Description and Business Overview
 Table 72. ICU Medical Inc. Intravenous Solutions (Colloids) Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 73. ICU Medical Inc. Intravenous Solutions (Colloids) Product
 Table 74. ICU Medical Inc. Recent Developments/Updates
 Table 75. B. Braun Melsungen AG Company Information
 Table 76. B. Braun Melsungen AG Description and Business Overview
 Table 77. B. Braun Melsungen AG Intravenous Solutions (Colloids) Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 78. B. Braun Melsungen AG Intravenous Solutions (Colloids) Product
 Table 79. B. Braun Melsungen AG Recent Developments/Updates
 Table 80. Fresenius Kabi AG Company Information
 Table 81. Fresenius Kabi AG Description and Business Overview
 Table 82. Fresenius Kabi AG Intravenous Solutions (Colloids) Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 83. Fresenius Kabi AG Intravenous Solutions (Colloids) Product
 Table 84. Fresenius Kabi AG Recent Developments/Updates
 Table 85. Baxter Company Information
 Table 86. Baxter Description and Business Overview
 Table 87. Baxter Intravenous Solutions (Colloids) Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 88. Baxter Intravenous Solutions (Colloids) Product
 Table 89. Baxter Recent Developments/Updates
 Table 90. Amanta Healthcare Company Information
 Table 91. Amanta Healthcare Description and Business Overview
 Table 92. Amanta Healthcare Intravenous Solutions (Colloids) Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 93. Amanta Healthcare Intravenous Solutions (Colloids) Product
 Table 94. Amanta Healthcare Recent Developments/Updates
 Table 95. Terumo Medical Corporation Company Information
 Table 96. Terumo Medical Corporation Description and Business Overview
 Table 97. Terumo Medical Corporation Intravenous Solutions (Colloids) Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 98. Terumo Medical Corporation Intravenous Solutions (Colloids) Product
 Table 99. Terumo Medical Corporation Recent Developments/Updates
 Table 100. Grifols S.A. Company Information
 Table 101. Grifols S.A. Description and Business Overview
 Table 102. Grifols S.A. Intravenous Solutions (Colloids) Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 103. Grifols S.A. Intravenous Solutions (Colloids) Product
 Table 104. Grifols S.A. Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Intravenous Solutions (Colloids) Distributors List
 Table 108. Intravenous Solutions (Colloids) Customers List
 Table 109. Intravenous Solutions (Colloids) Market Trends
 Table 110. Intravenous Solutions (Colloids) Market Drivers
 Table 111. Intravenous Solutions (Colloids) Market Challenges
 Table 112. Intravenous Solutions (Colloids) Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Intravenous Solutions (Colloids)
 Figure 2. Global Intravenous Solutions (Colloids) Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Intravenous Solutions (Colloids) Market Share by Type: 2025 & 2032
 Figure 4. Peripheral Parenteral Nutrition Product Picture
 Figure 5. Total Parenteral Nutrition Product Picture
 Figure 6. Global Intravenous Solutions (Colloids) Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Intravenous Solutions (Colloids) Market Share by Application: 2025 & 2032
 Figure 8. Hospital and Clinics
 Figure 9. Ambulatory
 Figure 10. Home Care
 Figure 11. Global Intravenous Solutions (Colloids) Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Intravenous Solutions (Colloids) Market Size (US$ Million), 2021–2032
 Figure 13. Global Intravenous Solutions (Colloids) Sales (K Units), 2021–2032
 Figure 14. Global Intravenous Solutions (Colloids) Average Price (USD/Unit), 2021–2032
 Figure 15. Intravenous Solutions (Colloids) Report Years Considered
 Figure 16. Intravenous Solutions (Colloids) Sales Share by Manufacturers in 2025
 Figure 17. Global Intravenous Solutions (Colloids) Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global Intravenous Solutions (Colloids) Players: Market Share by Revenue in Intravenous Solutions (Colloids) in 2025
 Figure 19. Intravenous Solutions (Colloids) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global Intravenous Solutions (Colloids) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America Intravenous Solutions (Colloids) Sales Market Share by Country (2021–2032)
 Figure 22. North America Intravenous Solutions (Colloids) Revenue Market Share by Country (2021–2032)
 Figure 23. U.S. Intravenous Solutions (Colloids) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada Intravenous Solutions (Colloids) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe Intravenous Solutions (Colloids) Sales Market Share by Country (2021–2032)
 Figure 26. Europe Intravenous Solutions (Colloids) Revenue Market Share by Country (2021–2032)
 Figure 27. Germany Intravenous Solutions (Colloids) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France Intravenous Solutions (Colloids) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. Intravenous Solutions (Colloids) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy Intravenous Solutions (Colloids) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia Intravenous Solutions (Colloids) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific Intravenous Solutions (Colloids) Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific Intravenous Solutions (Colloids) Revenue Market Share by Region (2021–2032)
 Figure 34. China Intravenous Solutions (Colloids) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan Intravenous Solutions (Colloids) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea Intravenous Solutions (Colloids) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India Intravenous Solutions (Colloids) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia Intravenous Solutions (Colloids) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Taiwan Intravenous Solutions (Colloids) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Indonesia Intravenous Solutions (Colloids) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Thailand Intravenous Solutions (Colloids) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Malaysia Intravenous Solutions (Colloids) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Philippines Intravenous Solutions (Colloids) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Latin America Intravenous Solutions (Colloids) Sales Market Share by Country (2021–2032)
 Figure 45. Latin America Intravenous Solutions (Colloids) Revenue Market Share by Country (2021–2032)
 Figure 46. Mexico Intravenous Solutions (Colloids) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Brazil Intravenous Solutions (Colloids) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Argentina Intravenous Solutions (Colloids) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Middle East and Africa Intravenous Solutions (Colloids) Sales Market Share by Country (2021–2032)
 Figure 50. Middle East and Africa Intravenous Solutions (Colloids) Revenue Market Share by Country (2021–2032)
 Figure 51. Turkey Intravenous Solutions (Colloids) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Saudi Arabia Intravenous Solutions (Colloids) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. U.A.E Intravenous Solutions (Colloids) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Global Sales Market Share of Intravenous Solutions (Colloids) by Type (2021–2032)
 Figure 55. Global Revenue Market Share of Intravenous Solutions (Colloids) by Type (2021–2032)
 Figure 56. Global Intravenous Solutions (Colloids) Price (USD/Unit) by Type (2021–2032)
 Figure 57. Global Sales Market Share of Intravenous Solutions (Colloids) by Application (2021–2032)
 Figure 58. Global Revenue Market Share of Intravenous Solutions (Colloids) by Application (2021–2032)
 Figure 59. Global Intravenous Solutions (Colloids) Price (USD/Unit) by Application (2021–2032)
 Figure 60. Intravenous Solutions (Colloids) Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Crystalloid Intravenous Fluids Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global IV Electrolyte Solutions Market Research Report 2024
Global Gold Colloid Solution Market Research Report 2025
Global IVF Liquid Consumables Market Research Report 2024
Global Sterile Intravenous IV Solution Market Insights Forecast to 2030
Global Intravenous Solutions Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Global IV Solution Bags Market Research Report 2024
Global Colloids Blood Plasma Market Research Report 2025
Global IVF Service Market Research Report 2024
Large Volume Intravenous Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global IV Fluid Bags Market Research Report 2024
Global IVF Software Market Insights Forecast to 2030
Global Injectable IVF Medications Market Research Report 2024
Global I V Intravenous Fluid Bags Market Research Report 2024
IVF Devices and Consumables Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Intravenous Fluid Bags Market Research Report 2025
Global In vitro Fertilization IVF Microscopes Market Research Report 2024
Global IVF Multi well Petri Dishes Market Research Report 2024
In Vitro Fertilization IVF Treatment Market
Non PVC IV Solution Bags Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions